Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Gemcitabine-based Adjuvant Chemotherapy for Patients with Advanced Gallbladder Cancer

MASAFUMI NAKAMURA, HIROSHI NAKASHIMA, TOSHIYA ABE, TAKAAKI ENSAKO, KOJI YOSHIDA and KEISUKE HINO
Anticancer Research June 2014, 34 (6) 3125-3129;
MASAFUMI NAKAMURA
1Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mnakamura@med.kawasaki-m.ac.jp
HIROSHI NAKASHIMA
1Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIYA ABE
1Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAAKI ENSAKO
1Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOJI YOSHIDA
2Department of Hepatology and Pancreatology, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEISUKE HINO
2Department of Hepatology and Pancreatology, Kawasaki Medical School, Kurashiki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 34 no. 6 3125-3129
PubMed 
24922682

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 24, 2014
  • Revision received April 22, 2014
  • Accepted April 23, 2014
  • Published online May 27, 2014.

Copyright & Usage 
Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MASAFUMI NAKAMURA1⇑,
  2. HIROSHI NAKASHIMA1,
  3. TOSHIYA ABE1,
  4. TAKAAKI ENSAKO1,
  5. KOJI YOSHIDA2 and
  6. KEISUKE HINO2
  1. 1Department of Digestive Surgery, Kawasaki Medical School, Kurashiki, Japan
  2. 2Department of Hepatology and Pancreatology, Kawasaki Medical School, Kurashiki, Japan
  1. Correspondence to: M. Nakamura, Department of Digestive Surgery, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan. Tel: +81 864621111, Fax: +81 864627897, e-mail: mnakamura{at}med.kawasaki-m.ac.jp
View Full Text

Cited By...

  • 13 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 34 (6)
Anticancer Research
Vol. 34, Issue 6
June 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Gemcitabine-based Adjuvant Chemotherapy for Patients with Advanced Gallbladder Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Gemcitabine-based Adjuvant Chemotherapy for Patients with Advanced Gallbladder Cancer
MASAFUMI NAKAMURA, HIROSHI NAKASHIMA, TOSHIYA ABE, TAKAAKI ENSAKO, KOJI YOSHIDA, KEISUKE HINO
Anticancer Research Jun 2014, 34 (6) 3125-3129;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Gemcitabine-based Adjuvant Chemotherapy for Patients with Advanced Gallbladder Cancer
MASAFUMI NAKAMURA, HIROSHI NAKASHIMA, TOSHIYA ABE, TAKAAKI ENSAKO, KOJI YOSHIDA, KEISUKE HINO
Anticancer Research Jun 2014, 34 (6) 3125-3129;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study
  • Effect of Adjuvant Gemcitabine Combined with Low-dose 5-Fluorouracil and Cisplatin Chemotherapy for Advanced Biliary Carcinoma
  • Clinicopathological Features of Surgically-resected Biliary Tract Cancer Following Chemo-radiation Therapy
  • Google Scholar

More in this TOC Section

  • Effect of Postoperative Muscle Loss After Resection of Non-small Cell Lung Cancer on Surgical Outcomes
  • The Prognostic Relevance of Preoperative CEA and CA19-9 for Ampulla of Vater Carcinoma
  • Difference in the Overall Survival Between Malignant Central Airway Obstruction Patients Treated by Transbronchial Microwave Ablation and Stent Placement: A Single-institution Retrospective Study
Show more Clinical Studies

Similar Articles

Keywords

  • Gallbladder cancer
  • curability
  • gemcitabine (GEM)
  • adjuvant chemotherapy
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire